&nbsp;

neilJohnson.jpg

Mar 2022

Regimen

NPAC(W)+PERTRAS(SC)

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Metastatic Breast Cancer

Drugs Used:

PERTuzumab / trastuzumab (subcut) (Unfunded),

nab-PACLitaxel (Unfunded with exceptions)

Quick Link(s):

Regimen Monograph

May 2022

Regimen

NPAC+PERTRAS(SC)

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Metastatic Breast Cancer

Drugs Used:

PERTuzumab / trastuzumab (subcut) (Unfunded),

nab-PACLitaxel (Unfunded with exceptions)

Quick Link(s):

Regimen Monograph

May 2022

Regimen

NIVL

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Adjuvant

Funding:

New Drug Funding Program

Nivolumab - Adjuvant Treatment of Urothelial Carcinoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

Aug 2024

Regimen

NIVL(MNT)

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab - First-line Treatment of Advanced Gastric, Esophageal, and Esophagogastric Junction Adenocarcinoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

Aug 2024

Document

Waiting Room Slides & Screen Savers - Other Languages.zip

May 2023

Document

no-harm.png

Sep 2024

Drug

nivolumab / relatlimab

Other Name(s): Opdualag™

Quick Link(s): Drug Monograph, Patient Info Sheet

Feb 2025

Document

Why-Biosimilars-are-Sold-in-Canada.png

Jan 2025

Document

What-to-Expect-When-Taking-a-Biosimilar.png

Jan 2025

Regimen

NIVL+IPIL

Cancer Type:

Skin,

Melanoma

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab,

ipilimumab

Quick Link(s):

Regimen Monograph

May 2025

Regimen

NIVL

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab